Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementationMohammad Chehelgerdi(Shahrekord University), Reza Akhavan‐Sigari(University of Tübingen)Molecular CancerOctober 9, 202310.1186/s12943-023-01865-0Cited by 956SaveCiteExport RISWatch citationsRelated PapersDiscovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks|Cell Cycle|2024|3